Clinical Trials Browser

Phase 2 × OTHER × Lubiprostone × Clear all

NCT07405736 2026-02-12

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms